Parabhdeep Gill, MD
Gynecology · Annapolis, MDNPI 1407859192
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,080 of the $7,478 with a category attached, or 67.9%. 31 manufacturers reported payments, led by Intuitive Surgical at 28.1% of the total. 2025 is the largest year on record at $3,210, 4.3 times the $741 reported in 2019.
Across 233 payments — averaging $32.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- AbbVie$590
- Therapeuticsmd, Inc.$484
- Astellas Pharma US Inc$479
- Baxter Healthcare$414
- Sumitomo Pharma America, Inc.$362
- plus $3K from 25 others
What the payments were for
- Travel & lodging$1,07314%
- Food & beverage$5,08068%
- Education$1,32418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $2,102 |
| AbbVie(2 entities) | 30 | $590 |
| Therapeuticsmd, Inc. | 17 | $484 |
| Astellas Pharma US Inc | 19 | $479 |
| Baxter Healthcare | 4 | $414 |
| Sumitomo Pharma America, Inc. | 14 | $362 |
| Hologic Sales And Service, LLC | 7 | $352 |
| Sage Therapeutics, LLC | 15 | $342 |
| Pfizer | 20 | $306 |
| Aspira Women's Health Inc | 3 | $267 |
| Millicent US Inc | 21 | $234 |
| Myovant Sciences Inc. | 13 | $220 |
| Amgen | 11 | $202 |
| Exeltis, USA Inc. | 9 | $161 |
| Caldera Medical, Inc | 1 | $126 |
| AMAG Pharmaceuticals, Inc. | 8 | $123 |
| Organon | 5 | $119 |
| Mayne Pharma Commercial LLC | 7 | $99 |
| Dysis Medical, Inc. | 1 | $72 |
| Exact Sciences | 3 | $64 |
| Bayer | 4 | $60 |
| Merck | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Coopersurgical, Inc. | 2 | $40 |
| Renovia Inc | 1 | $36 |
| Ferring Pharmaceuticals Inc. | 1 | $29 |
| Novo Nordisk | 1 | $28 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Aesculap, Inc. | 1 | $16 |
| Minerva Surgical, Inc | 1 | $15 |
| Meditrina | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,043
- DAVINCI XI$1,000
- TISSEEL$368
- ACESSA PROVU SYSTEM$131
- Desara$126
- IMVEXXY$117
- MYFEMBREE$115
- BIJUVA$104
How this compares
$7,478 in reported general payments places this provider in the 85th percentile of 79 gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 19 | $9,732 |
| Estradiol | 103 | $9,063 |
| YuvafemEstradiol | 20 | $4,095 |
| Clobetasol Propionate | 15 | $1,170 |
| Fluconazole | 13 | $34 |
| Misoprostol | 13 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $306 | $9,73219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 79 gynecology providers in Maryland.
Other gynecology in Annapolis
- Richard MarvelAnnapolis$40K
- Hector Gonzalez GarciaAnnapolis$23K
- Julia LubskyAnnapolis$4K
- Karen HardartAnnapolis$3K
- Lawrence PrichepAnnapolis$2K
- Debra Hardy CartwrightAnnapolis$493
- Vadim MorozovBaltimore$394K
- Andrew LondonLutherville$335K
- Ann PetersBaltimore$25K
- David ZisowForest Hill$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.